Purchase Order 75D30118P03279
Award Date
9/13/18
Potential Completion Date
9/12/19
Potential Value
$150K
Federal Agency
CDC Pittsburgh
Awardee
Kephera Diagnostics LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase 1 contract to Lynntech Inc., a small business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis-associated epilepsy. The firm fixed-price contract has a potential value of $149,875 and was awarded on September 17, 2018, with a completion date of September 16, 2019. The contract was set aside for small businesses.
This contract was awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) to Aptagen LLC, a small business contractor, to conduct research to find human carriers of taeniasis in order to prevent neurocysticercosis-associated epilepsy. The contract, valued at $126,680, was issued under the CDC's Small Business Innovative Research (SBIR) program and is a Firm Fixed Price Purchase Order. Aptagen LLC, a limited liability company with over 30 years...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The $299,997.00 contract was awarded to Kephera Diagnostics LLC, a for-profit limited liability company, to develop screening and point-of-care diagnostic assays for the liver fluke infections Opisthorchis viverrini and Clonorchis sinensis. This SBIR contract, which was set...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis epilepsy. The $150,000 firm-fixed-price contract was awarded on September 17, 2018 with a completion date of September 16, 2019. Qoolabs Inc. has received over $4 million in prime federal...
This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a small business, for the discovery and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is a Small Business Innovation Research (SBIR) Phase I award, meaning it supports early-stage research and development efforts. The work will be performed in Framingham,...
This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Kephera Diagnostics LLC, a for-profit limited liability company. The contract is part of the SBIR 133 program, which does not have a set-aside designation. The contract focuses on advancing Kephera Diagnostics' research and development of innovative diagnostic solutions for infectious diseases, with a particular emphasis on neglected tropical...
This $221,889 firm fixed-price SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company, for "Diagnostics to Enable Malaria and Neglected Tropical Diseases". The contract originated from the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS 2018-1, which sought...
This is a $1,999,961.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI) to Kephera Diagnostics LLC, a for-profit limited liability company. The contract was set aside for small businesses under the Small Business Innovation Research (SBIR) program. The contract is for the development of an in vitro diagnostic test for the liver flukes Opisthorchis viverrini and Clonorchis sinensis, with a period of performance through March 15, 2026. Kephera Diagnostics specializes in...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $989,300.00 Firm Fixed Price Definitive Contract to Aptagen LLC, a for-profit limited liability company, to provide SBIR Phase II funding for finding human carriers of taeniasis to prevent neurocysticercosis associated epilepsy. The contract, which does not have a set-aside designation, was awarded on September 30, 2019 with a completion date of September 29, 2021. Aptagen LLC has over...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...